Skip to main content
Erschienen in: Tumor Biology 4/2014

01.04.2014 | Research Article

N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy

verfasst von: Jingyu Deng, Rupeng Zhang, Yuan Pan, Baogui Wang, Liangliang Wu, Xishan Hao, Han Liang

Erschienen in: Tumor Biology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to explore the prognostic prediction rationality of the seventh edition N stage for gastric cancer (GC) patients who underwent the limited lymphadenectomy. Clinicopathological data of 769 GC patients who underwent the curative resection between 1997 and 2006 were analyzed for demonstration that the seventh edition N stage had the significant superiorities of prognostic prediction to the patients who underwent the limited lymphadenectomy. Although the extent of lymphadenectomy was associated with the overall survival (OS) of gastric cancer (GC) patients, the N stages of the seventh edition of the TNM Classification were identified as the most intensively independent predictors of GC prognosis. Using stratum analysis, the 5-year survival rate of patients who underwent limited lymphadenectomy was observed to be significantly different from that of patients who underwent extended lymphadenectomy, regardless of the extent of lymph node metastasis. Multinomial logistic regression analysis revealed that combining the extents of lymph node metastasis and lymphadenectomy could improve the prediction accuracy of patient survival status. Case control analysis showed that regardless of the extent of lymphadenectomy, the seventh edition N stages featured significant superiority for OS evaluation of GC patients. The seventh edition N stage had the prediction rationality for the OS of GC patients who underwent the limited lymphadenectomy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma—2nd English Edition. Gastric Cancer. 1998;1:10–24.PubMedCrossRef Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma—2nd English Edition. Gastric Cancer. 1998;1:10–24.PubMedCrossRef
2.
Zurück zum Zitat Sobin LH, Wittekind CH. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley & Sons; 1997. Sobin LH, Wittekind CH. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley & Sons; 1997.
3.
Zurück zum Zitat Hayashi H, Ochiai T, Suzuki T, Shimada H, Hori S, Takeda A, et al. Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery. 2000;127:129–35.PubMedCrossRef Hayashi H, Ochiai T, Suzuki T, Shimada H, Hori S, Takeda A, et al. Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery. 2000;127:129–35.PubMedCrossRef
4.
Zurück zum Zitat Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P’eng FK. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut. 1996;38:525–7.PubMedCentralPubMedCrossRef Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P’eng FK. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut. 1996;38:525–7.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection. J Surg Oncol. 2008;98:343–8.PubMedCrossRef Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection. J Surg Oncol. 2008;98:343–8.PubMedCrossRef
6.
Zurück zum Zitat Sobin L, Gospodarowicz M, Wittekind C., editors. TNM classification of malignant tumours seventh edition. International Union Against Cancer (UICC). New York: Wiley; 2009. Sobin L, Gospodarowicz M, Wittekind C., editors. TNM classification of malignant tumours seventh edition. International Union Against Cancer (UICC). New York: Wiley; 2009.
7.
Zurück zum Zitat Deng JY, Liang H, Sun D, Wang D, Pan Y. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. A Single Clinical Center Report of New N Stage. Ann Surg Oncol. 2010;17:1259–66.PubMedCrossRef Deng JY, Liang H, Sun D, Wang D, Pan Y. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. A Single Clinical Center Report of New N Stage. Ann Surg Oncol. 2010;17:1259–66.PubMedCrossRef
8.
Zurück zum Zitat Ikeguchi M, Murakami D, Kanaji S, Ohro S, Maeta Y, Yamaguchi KI, et al. Lymph node metastasis of gastric cancer: comparison of Union International Contra Cancer and Japanese systems. ANZ J Surg. 2004;74:852–4.PubMedCrossRef Ikeguchi M, Murakami D, Kanaji S, Ohro S, Maeta Y, Yamaguchi KI, et al. Lymph node metastasis of gastric cancer: comparison of Union International Contra Cancer and Japanese systems. ANZ J Surg. 2004;74:852–4.PubMedCrossRef
9.
Zurück zum Zitat D'Ugo D, Pacelli F, Persiani R, Pende V, Ianni A, Papa V, et al. Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomy. World J Surg. 2002;26:672–7.PubMedCrossRef D'Ugo D, Pacelli F, Persiani R, Pende V, Ianni A, Papa V, et al. Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomy. World J Surg. 2002;26:672–7.PubMedCrossRef
10.
Zurück zum Zitat Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang DC. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbeck Arch Surg. 2011;396:615–23.CrossRef Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang DC. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbeck Arch Surg. 2011;396:615–23.CrossRef
11.
Zurück zum Zitat Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic lymph node dissection for gastric cancer. N Engl J Med. 2008;359:453–62.PubMedCrossRef Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic lymph node dissection for gastric cancer. N Engl J Med. 2008;359:453–62.PubMedCrossRef
12.
Zurück zum Zitat Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908–14.PubMedCrossRef Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908–14.PubMedCrossRef
13.
Zurück zum Zitat Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522–30.PubMedCentralPubMedCrossRef Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522–30.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Songun I, Putter H, Kranenbarg EM-K, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.PubMedCrossRef Songun I, Putter H, Kranenbarg EM-K, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.PubMedCrossRef
15.
Zurück zum Zitat Degiuli M, Sasako M, Ponti A. Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643–9.PubMedCrossRef Degiuli M, Sasako M, Ponti A. Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643–9.PubMedCrossRef
16.
Zurück zum Zitat Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol. 1994;10:12–20.PubMedCrossRef Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol. 1994;10:12–20.PubMedCrossRef
17.
Zurück zum Zitat Jaehne J, Meyer HJ, Maschek H, Geerlings H, Bruns E, Pichlmayr R. Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg. 1992;127:290–4.PubMedCrossRef Jaehne J, Meyer HJ, Maschek H, Geerlings H, Bruns E, Pichlmayr R. Lymphadenectomy in gastric adenocarcinoma: a prospective and prognostic study. Arch Surg. 1992;127:290–4.PubMedCrossRef
18.
19.
Zurück zum Zitat Smith DD, Schwarz RR, Schwartz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-Population Database. JCO. 2005;23:7114–24.CrossRef Smith DD, Schwarz RR, Schwartz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-Population Database. JCO. 2005;23:7114–24.CrossRef
20.
Zurück zum Zitat Nitsche U, Maak M, Schuster T, Künzli B, Langer R, Slotta-Huspenina J, et al. Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg. 2011;254:793–800.PubMedCrossRef Nitsche U, Maak M, Schuster T, Künzli B, Langer R, Slotta-Huspenina J, et al. Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg. 2011;254:793–800.PubMedCrossRef
21.
Zurück zum Zitat Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352–61.PubMedCrossRef Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352–61.PubMedCrossRef
22.
Zurück zum Zitat Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X. Prognosis of gastric cancer patients with negative node metastasis following curative resection. Outcomes of the Survival and Recurrence. Can J Gastroenterol. 2008;22:835–9.PubMedCentralPubMed Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X. Prognosis of gastric cancer patients with negative node metastasis following curative resection. Outcomes of the Survival and Recurrence. Can J Gastroenterol. 2008;22:835–9.PubMedCentralPubMed
23.
Zurück zum Zitat Ichikura T, Ogawa T, Chochi K, Kawabata T, Sugasawa H, Mochizuki H. Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma. World J Surg. 2003;27:330–3.PubMedCrossRef Ichikura T, Ogawa T, Chochi K, Kawabata T, Sugasawa H, Mochizuki H. Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma. World J Surg. 2003;27:330–3.PubMedCrossRef
24.
Zurück zum Zitat Bilici A, Ustaalioglu BB, Gumus M, Seker M, Yilmaz B, Kefeli U, et al. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Onkologie. 2010;33:101–5.PubMedCrossRef Bilici A, Ustaalioglu BB, Gumus M, Seker M, Yilmaz B, Kefeli U, et al. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Onkologie. 2010;33:101–5.PubMedCrossRef
25.
Zurück zum Zitat Deng JY, Liang H. Does metastatic lymph node ratio really suit for prognostic prediction of the D1 lymphadenectomy? Ann Surg Oncol. 2010;17:1718.PubMedCrossRef Deng JY, Liang H. Does metastatic lymph node ratio really suit for prognostic prediction of the D1 lymphadenectomy? Ann Surg Oncol. 2010;17:1718.PubMedCrossRef
26.
Zurück zum Zitat Deng J, Liang H. Discussion the applicability of positive lymph node ratio as a proper N-staging for prediction the prognosis of gastric cancer after curative surgery plus extended lymphadenectomy. Ann Surg. 2012;256:e35–6.PubMedCrossRef Deng J, Liang H. Discussion the applicability of positive lymph node ratio as a proper N-staging for prediction the prognosis of gastric cancer after curative surgery plus extended lymphadenectomy. Ann Surg. 2012;256:e35–6.PubMedCrossRef
27.
Zurück zum Zitat Deng J, Liang H, Sun D, Pan Y. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res. 2010;161:47–53.PubMedCrossRef Deng J, Liang H, Sun D, Pan Y. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res. 2010;161:47–53.PubMedCrossRef
28.
Zurück zum Zitat Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, et al. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60–9.PubMedCrossRef Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, et al. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60–9.PubMedCrossRef
29.
Zurück zum Zitat Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, et al. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg. 2007;96:35–40.PubMed Danielson H, Kokkola A, Kiviluoto T, Sirén J, Louhimo J, Kivilaakso E, et al. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg. 2007;96:35–40.PubMed
30.
Zurück zum Zitat Díaz de Liaño A, Yárnoz C, Artieda C, Aguilar R, Viana S, Artajona A, et al. Results of R0 surgery with D2 lymphadenectomy for the treatment of localized gastric cancer. Clin Transl Oncol. 2009;11:178–82.PubMedCrossRef Díaz de Liaño A, Yárnoz C, Artieda C, Aguilar R, Viana S, Artajona A, et al. Results of R0 surgery with D2 lymphadenectomy for the treatment of localized gastric cancer. Clin Transl Oncol. 2009;11:178–82.PubMedCrossRef
31.
Zurück zum Zitat Putchakayala K, Difronzo LA. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma. Am Surg. 2011;77:1326–9.PubMed Putchakayala K, Difronzo LA. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma. Am Surg. 2011;77:1326–9.PubMed
32.
Zurück zum Zitat Otsuji E, Kuriu Y, Ichikawa D, Ochiai T, Okamoto K, Hagiwara A, et al. Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma. Hepatogastroenterology. 2008;55:755–9.PubMed Otsuji E, Kuriu Y, Ichikawa D, Ochiai T, Okamoto K, Hagiwara A, et al. Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma. Hepatogastroenterology. 2008;55:755–9.PubMed
33.
Zurück zum Zitat Kikuchi S, Kurita A, Natsuya K, Sakuramoto S, Kobayashi N, Shimao H, et al. First drainage lymph node(s) in gastric cancer: analysis of the topographical pattern of lymph node metastasis in patients with pN-1 stage tumors. Anticancer Res. 2003;23:601–4.PubMed Kikuchi S, Kurita A, Natsuya K, Sakuramoto S, Kobayashi N, Shimao H, et al. First drainage lymph node(s) in gastric cancer: analysis of the topographical pattern of lymph node metastasis in patients with pN-1 stage tumors. Anticancer Res. 2003;23:601–4.PubMed
34.
Zurück zum Zitat Yoshikawa T, Sasako M, Sano T, Nashimoto A, Kurita A, Tsujinaka T, et al. Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial. Br J Surg. 2006;93:1526–9.PubMedCrossRef Yoshikawa T, Sasako M, Sano T, Nashimoto A, Kurita A, Tsujinaka T, et al. Stage migration caused by D2 dissection with para-aortic lymphadenectomy for gastric cancer from the results of a prospective randomized controlled trial. Br J Surg. 2006;93:1526–9.PubMedCrossRef
Metadaten
Titel
N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy
verfasst von
Jingyu Deng
Rupeng Zhang
Yuan Pan
Baogui Wang
Liangliang Wu
Xishan Hao
Han Liang
Publikationsdatum
01.04.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1428-1

Weitere Artikel der Ausgabe 4/2014

Tumor Biology 4/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.